News
NAII
3.400
-0.58%
-0.020
Weekly Report: what happened at NAII last week (0202-0206)?
Weekly Report · 3d ago
Weekly Report: what happened at NAII last week (0126-0130)?
Weekly Report · 02/02 10:05
Weekly Report: what happened at NAII last week (0119-0123)?
Weekly Report · 01/26 10:05
Weekly Report: what happened at NAII last week (0112-0116)?
Weekly Report · 01/19 10:10
Niche Focus & Regulation Shape the Future of Healthcare Firms
NASDAQ · 01/15 16:24
Weekly Report: what happened at NAII last week (0105-0109)?
Weekly Report · 01/12 10:09
Weekly Report: what happened at NAII last week (1229-0102)?
Weekly Report · 01/05 10:04
Weekly Report: what happened at NAII last week (1222-1226)?
Weekly Report · 12/29/2025 10:04
Weekly Report: what happened at NAII last week (1215-1219)?
Weekly Report · 12/22/2025 10:03
Natural Alternatives Resolves Credit Agreement Issues
TipRanks · 12/17/2025 22:28
NAI Secures Waiver for Loan Covenant Defaults from Wells Fargo
Reuters · 12/17/2025 22:14
Weekly Report: what happened at NAII last week (1208-1212)?
Weekly Report · 12/15/2025 10:09
Natural Alternatives International Holds Annual Stockholder Meeting
TipRanks · 12/12/2025 11:33
Natural Alternatives International Inc. Held Annual Shareholder Meeting
Reuters · 12/12/2025 11:02
Weekly Report: what happened at NAII last week (1201-1205)?
Weekly Report · 12/08/2025 10:08
Weekly Report: what happened at NAII last week (1124-1128)?
Weekly Report · 12/01/2025 10:04
Weekly Report: what happened at NAII last week (1117-1121)?
Weekly Report · 11/24/2025 10:08
Weekly Report: what happened at NAII last week (1110-1114)?
Weekly Report · 11/17/2025 10:08
Natural Alternatives GAAP EPS of -$0.05, revenue of $37.73M
Seeking Alpha · 11/12/2025 22:30
Natural Alternatives Q1 net loss narrows
Reuters · 11/12/2025 21:53
More
Webull provides a variety of real-time NAII stock news. You can receive the latest news about Naturl Alt Intl through multiple platforms. This information may help you make smarter investment decisions.
About NAII
Natural Alternatives International, Inc. is a formulator, manufacturer and marketer of nutritional supplements. Its primary business activity is to provide private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbs, and other nutritional supplements, as well as other health care products, to consumers both within and outside the United States. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer ecommerce channels, and retail stores. It manufactures products in a variety of forms, including capsules, tablets, chewable wafers, and powders to accommodate a variety of its customer’s preferences. It also seeks to commercialize its patent and trademarks through the direct distribution and sale of CarnoSyn, SR CarnoSyn, TriBsyn, new contract manufacturing opportunities, and various license, royalty, and similar arrangements.